Do geriatric conditions increase risk of adverse drug reactions in ambulatory elders? Results from the VA GEM Drug Study
- PMID: 21321003
- PMCID: PMC3055283
- DOI: 10.1093/gerona/glq236
Do geriatric conditions increase risk of adverse drug reactions in ambulatory elders? Results from the VA GEM Drug Study
Abstract
Background: Many clinicians prescribe cautiously to older adults with common geriatric conditions for fear of causing adverse drug reactions (ADRs). However, little is known about the association between these conditions and risk of ADRs.
Methods: Using data from the VA Geriatric Evaluation and Management Drug Study, we determined any, preventable, and serious ADRs in 808 elders for 12 months after hospital discharge using a validated process involving patient self-report and chart review adjudicated by two health care professionals. Eight common geriatric conditions (activities of daily living, dementia, incontinence, falls, difficulty ambulating, malnourishment, depression, and prolonged bed rest) were evaluated at study baseline through self-report and structured assessments. We used Poisson regression to model the relationship between these geriatric conditions and ADRs.
Results: Participants had a mean of 2.9 ± 1.2 geriatric conditions. Over the 12-month follow-up period, 497 ADRs occurred in 269 participants, including 187 ADRs considered preventable and 127 considered severe. On multivariable analyses, participants with dependency in one or more activities of daily living were less likely to suffer ADRs than those who were fully independent (incidence rate ratio: 0.78, 95% confidence interval = 0.62-1.00). None of the other seven geriatric conditions assessed were associated with ADR risk. Results were similar for preventable and serious ADRs, although participants with a history of falls were more likely to develop serious ADRs (incidence rate ratio: 1.49, 95% confidence interval = 1.00-2.21).
Conclusions: Many geriatric conditions were not associated with risk of ADRs. Although it is prudent to prescribe judiciously in patients with these conditions, excessive caution may not be warranted.
Figures
Similar articles
-
Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population.J Am Geriatr Soc. 2011 Apr;59(4):615-21. doi: 10.1111/j.1532-5415.2011.03331.x. Epub 2011 Mar 15. J Am Geriatr Soc. 2011. PMID: 21410446 Free PMC article. Clinical Trial.
-
Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay.J Gerontol A Biol Sci Med Sci. 2006 May;61(5):511-5. doi: 10.1093/gerona/61.5.511. J Gerontol A Biol Sci Med Sci. 2006. PMID: 16720750
-
Geriatric conditions as predictors of increased number of hospital admissions and hospital bed days over one year: findings of a nationwide cohort of older adults from Taiwan.Arch Gerontol Geriatr. 2014 Jul-Aug;59(1):169-74. doi: 10.1016/j.archger.2014.02.002. Epub 2014 Feb 10. Arch Gerontol Geriatr. 2014. PMID: 24588875
-
Geriatric conditions and the risk of adverse drug reactions in older adults: a review.Drug Saf. 2012 Jan;35 Suppl 1:55-61. doi: 10.1007/BF03319103. Drug Saf. 2012. PMID: 23446786 Review.
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
Cited by
-
A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial.Eur Geriatr Med. 2024 Aug 2. doi: 10.1007/s41999-024-01025-7. Online ahead of print. Eur Geriatr Med. 2024. PMID: 39095682
-
Potentially inappropriate prescriptions of antithrombotic therapies in older outpatients: a French multicenter cross-sectional study.Eur Geriatr Med. 2019 Jun;10(3):473-481. doi: 10.1007/s41999-019-00176-2. Epub 2019 Mar 18. Eur Geriatr Med. 2019. PMID: 34652793
-
The Need for Actions Against Polypharmacy in Older People With Frailty.Ann Geriatr Med Res. 2018 Sep;22(3):111-116. doi: 10.4235/agmr.2018.22.3.111. Epub 2018 Sep 30. Ann Geriatr Med Res. 2018. PMID: 32743259 Free PMC article. Review.
-
Implementation of integrated geriatric care at a German hospital: a case study to understand when and why beneficial outcomes can be achieved.BMC Health Serv Res. 2017 Mar 7;17(1):180. doi: 10.1186/s12913-017-2105-7. BMC Health Serv Res. 2017. PMID: 28270122 Free PMC article.
-
Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review.Rev Lat Am Enfermagem. 2016 Sep 1;24:e2800. doi: 10.1590/1518-8345.1316.2800. Rev Lat Am Enfermagem. 2016. PMID: 27598380 Free PMC article. Review.
References
-
- Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142–1148. - PubMed
-
- Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–1564. - PubMed
-
- Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52(8):1349–1354. - PubMed
-
- Chrischilles E, Rubenstein L, Van Gilder R, Voelker M, Wright K, Wallace R. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc. 2007;55(1):29–34. - PubMed
-
- Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003;1(2):82–89. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- HS018721/HS/AHRQ HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- R01AG027017/AG/NIA NIH HHS/United States
- K23 AG030999/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- R56 AG027017/AG/NIA NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- HS017695/HS/AHRQ HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
